Medplus Health Services Limited (MEDPLUS) - Net Assets
Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has net assets worth Rs19.75 Billion INR (≈ $213.55 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs39.33 Billion ≈ $425.29 Million USD) and total liabilities (Rs19.58 Billion ≈ $211.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MEDPLUS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs19.75 Billion |
| % of Total Assets | 50.21% |
| Annual Growth Rate | 31.44% |
| 5-Year Change | 39.33% |
| 10-Year Change | N/A |
| Growth Volatility | 34.76 |
Medplus Health Services Limited - Net Assets Trend (2019–2026)
This chart illustrates how Medplus Health Services Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Medplus Health Services Limited market cap and net worth.
Annual Net Assets for Medplus Health Services Limited (2019–2026)
The table below shows the annual net assets of Medplus Health Services Limited from 2019 to 2026. Also explore MEDPLUS year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs19.75 Billion ≈ $213.55 Million |
+13.49% |
| 2025-03-31 | Rs17.40 Billion ≈ $188.16 Million |
+10.30% |
| 2024-03-31 | Rs15.77 Billion ≈ $170.59 Million |
+5.83% |
| 2023-03-31 | Rs14.91 Billion ≈ $161.19 Million |
+5.17% |
| 2022-03-31 | Rs14.17 Billion ≈ $153.27 Million |
+93.85% |
| 2021-03-31 | Rs7.31 Billion ≈ $79.07 Million |
+38.18% |
| 2020-03-31 | Rs5.29 Billion ≈ $57.22 Million |
+81.60% |
| 2019-03-31 | Rs2.91 Billion ≈ $31.51 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medplus Health Services Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs240.11 Million | 1.22% |
| Other Components | Rs19.51 Billion | 98.78% |
| Total Equity | Rs19.75 Billion | 100.00% |
Medplus Health Services Limited Competitors by Market Cap
The table below lists competitors of Medplus Health Services Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Beijing Join-Cheer Software Co Ltd
SHE:002279
|
$856.68 Million |
|
Fujian Boss Software Development Co Ltd
SHE:300525
|
$856.81 Million |
|
CHINA RISUN GROUP HD-10
F:45Y
|
$856.94 Million |
|
Savencia SA
PA:SAVE
|
$857.00 Million |
|
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082
|
$856.60 Million |
|
Fujian Longxi Bearing Group Co Ltd
SHG:600592
|
$855.96 Million |
|
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
|
$855.79 Million |
|
Pet Valu Holdings Ltd
TO:PET
|
$855.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medplus Health Services Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 17,405,610,000 to 19,753,590,000, a change of 2,347,980,000 (13.5%).
- Net income of 2,196,490,000 contributed positively to equity growth.
- New share issuances of 99,300,000 increased equity.
- Other comprehensive income decreased equity by 622,310,000.
- Other factors increased equity by 674,500,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs2.20 Billion | +11.12% |
| Share Issuances | Rs99.30 Million | +0.5% |
| Other Comprehensive Income | Rs-622.31 Million | -3.15% |
| Other Changes | Rs674.50 Million | +3.41% |
| Total Change | Rs- | 13.49% |
Book Value vs Market Value Analysis
This analysis compares Medplus Health Services Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.01x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 24.45x to 4.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | Rs26.98 | Rs659.65 | x |
| 2020-03-31 | Rs48.80 | Rs659.65 | x |
| 2021-03-31 | Rs67.44 | Rs659.65 | x |
| 2022-03-31 | Rs126.05 | Rs659.65 | x |
| 2023-03-31 | Rs124.63 | Rs659.65 | x |
| 2024-03-31 | Rs131.47 | Rs659.65 | x |
| 2025-03-31 | Rs145.02 | Rs659.65 | x |
| 2026-03-31 | Rs164.49 | Rs659.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medplus Health Services Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.12%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.19%
- • Asset Turnover: 1.75x
- • Equity Multiplier: 1.99x
- Recent ROE (11.12%) is above the historical average (5.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 4.09% | 0.52% | 2.37x | 3.29x | Rs-172.13 Million |
| 2020 | 0.41% | 0.08% | 2.13x | 2.56x | Rs-506.00 Million |
| 2021 | 8.74% | 2.08% | 1.96x | 2.14x | Rs-91.97 Million |
| 2022 | 6.76% | 2.53% | 1.46x | 1.83x | Rs-459.75 Million |
| 2023 | 3.34% | 1.09% | 1.63x | 1.88x | Rs-993.55 Million |
| 2024 | 4.15% | 1.16% | 1.87x | 1.90x | Rs-923.20 Million |
| 2025 | 8.64% | 2.45% | 1.83x | 1.93x | Rs-237.34 Million |
| 2026 | 11.12% | 3.19% | 1.75x | 1.99x | Rs221.13 Million |
Industry Comparison
This section compares Medplus Health Services Limited's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $12,074,822,000
- Average return on equity (ROE) among peers: 51.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medplus Health Services Limited (MEDPLUS) | Rs19.75 Billion | 4.09% | 0.99x | $856.68 Million |
| Sastasundar Ventures Limited (SASTASUNDR) | $12.07 Billion | 51.91% | 0.06x | $108.35 Million |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more